ABSTRACT: This study characterizes the metabolic profile of synovial fluid after intra-articular ankle fracture with an emphasis on changes in the lipid profile. Bilateral ankle synovial fluid from 19 patients with unilateral intra-articular ankle fracture was submitted for metabolic profiling. Contralateral ankle synovial fluid from each patient served as a matched control. Seven patients participated in a second bilateral synovial fluid collection after 6 months. Random forest classification, matched pairs t-tests (a < 0.01), repeated measures ANOVA with post-test contrasts (a < 0.01), correlation to cytokines and matrix metalloproteinases, and fracture and injury classification analyses yielded key lipid biomarkers in synovial fluid following intra-articular fracture. Free fatty acids, sphingomyelins, and lysolipids demonstrated significant elevation in fractured ankles at baseline. Fatty acids and sphingomyelins showed a significant decrease 6 months post-surgery. Random forest analysis showed predominantly fatty acids differentiating between groups. Significant correlations included fatty acids, sphingomyelins, and lysolipids with inflammatory cytokines and matrix metalloproteinases. Fracture classification showed increased fatty acids, lysolipids, and inositol metabolites as fracture severity increased. Fatty acid and sn-1 lysolipid elevation could be detrimental to the joint, as these strongly correlated with matrix metalloproteinases and TNF-a. This elevation also suggests involvement of phospholipase A 2 , a potential target for therapeutic intervention. Together with elevated 2-hydroxyl fatty acids, these findings suggest elevated sn-1 lysolipids, sphingomyelins, and subsequent lipid metabolites in synovial fluid as biomarkers of ankle injury. Reversal of this signature after 6 months suggests temporary involvement of these metabolites in disease progression, although they may activate signaling pathways which drive progression to osteoarthritis. ß
Osteoarthritis (OA) contributes to joint pain and disability and accounts for 10% of the musculoskeletal global burden of disease, 1 including approximately 27 million Americans. 2 Post-traumatic osteoarthritis (PTOA) results from acute joint trauma such as a meniscal tear, 3 ligament injury, 3 or intra-articular (IA) fracture, 4, 5 and accounts for 12% of lower-extremity OA. 6 An IA fracture increases the risk of progressing to OA by more than 20-fold. 7 PTOA is the most common etiology of OA in the ankle joint with a prevalence of 70-78% and develops over a period as long as 21 years after the initial injury. [8] [9] [10] Additional factors for determining incidence and severity of ankle PTOA include severe sprain, 11, 12 joint dislocation, age at the time of injury, time since injury onset and surgery, and obesity. 5, 13 Initial post-traumatic pathologic changes in the joint and subsequent progression to PTOA are poorly understood. Methods for diagnosing progression of PTOA remain limited to clinical exam and plain radiograph evaluation despite evidence that joint radiographs show no correlation to exam findings in early disease states. 14 The post-traumatic etiology of OA is particularly burdensome as it predominately affects young adults, 9, 13 for whom the standard treatments of joint replacement or fusion are undesirable. However, characteristics of the post-traumatic etiology of OA which enable understanding of disease progression include known time of injury and a defined period of time to development of PTOA. 10 This provides an advantage for interventions which can be designed to limit acute joint damage and delay or prevent onset of PTOA. Currently, no such therapies exist that successfully treat acute joint injury; thus PTOA remains a prevalent health problem in the United States and worldwide.
Although no correlation exists between clinical outcomes and articular surface incongruities alone postfracture, 15, 16 studies suggest a direct relationship between energy absorbed by the joint surface during acute injury and IA fracture severity, which has also been correlated with bone and synovium pathology and chondrocyte death. 17, 18 Acute joint injury is also associated with increased pro-inflammatory cytokines, inflammatory cell infiltrates, and complement activation in the synovial fluid (SF). [19] [20] [21] [22] Our recent work showed significantly elevated inflammatory cytokines and matrix metalloproteinases (MMPs) in the SF after acute IA ankle fracture, including IL-1b, IL-10, IL-6, IL-8, TNF-a, MMP-1, MMP-2, MMP-3, MMP-9, and MMP-10 compared to uninjured, contralateral control ankles.
SF also acts as a repository for lipid products of bone, cartilage, and synovium metabolism. Lipids lubricate IA structures 25 and changes in SF lipid composition contribute to OA and have historically been associated with injury, inflammation, and fractrure. 26 For example, increased levels of SF phospholipids are associated with damaged articular cartilage surfaces in early and late OA, as well as rheumatoid arthritis (RA). 25 The lipid profile in SF of injured knees without fracture is thought to be due to a damaged blood-synovial barrier which yields a lipid profile similar to blood, 27 a damaged IA fat pad which yields increased triglycerides, 26 or damaged joint structures which yields a profile with decreased triglycerides and increased phospholipids. 28 These earlier studies were performed using simple lipid separation methods and column chromatography to provide the first data suggesting the importance of lipid changes in characterizing disease states in the joint. 26, 29 More recent studies have used electrospray ionization mass spectrometry to demonstrate that early OA, late OA, and RA show significantly different lipid profiles. 25 In previous work, we used ultrahigh performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and gas chromatography/mass spectrometry (GC/MS) for high throughput characterization of the global SF metabolic profile of synovial tissue samples from knees with end-stage OA, 30 and ankle PTOA. 31 The purpose of the current work was to characterize the global metabolic profile of SF after IA ankle fracture with an emphasis on changes in the lipid profile.
METHODS

Patient Enrollment and Study Design
This was a level three evidence retrospective cohort study. All procedures and patient enrollment were performed after obtaining informed consent and Institutional Review Board approval. Twenty patients with unilateral IA ankle fracture requiring surgical open reduction and internal fixation were enrolled in this study (mean age ¼ 42 years; Table 1 ). IA ankle fracture was defined as any fracture of the fibula or tibia where the fracture line extended to the surface of the articular cartilage of the ankle joint on plain radiographs. The contralateral ankle joint of each patient served as a matched control. Patients were excluded from the study due to a prior history of ankle trauma or pain in either ankle, radiographic evidence of arthritis (e.g., joint incongruity, joint space narrowing, subchondral sclerosis, or osteophyte formation), co-morbidities including diabetes, hemophilia, or a systemic inflammatory disease such as RA, or injury not requiring surgical intervention. All enrolled patients underwent ankle arthrodesis or joint replacement surgery. Seven patients participated in a second bilateral SF joint collection during a surgical procedure for syndesmotic screw removal 6 months after the initial procedure. No differences were grossly observed amongst patient demographics including classification by sex, incidence of fracture type, or the number of days post-fracture. Therefore, the patient population was pooled together for analyses to increase the statistical power.
Ankle Joint Lavage and SF Aspiration SF was obtained from bilateral ankles at the time of surgery (mean time ¼ 17 days), and again 6 months post-surgery (Table 1) . After lower extremity surgical scrub and draping, lavage, and arthrocentesis were performed on each ankle joint using an 18-gauge needle and 10cc syringe filled with 7cc of sterile saline. The needle was inserted through the standard anteromedial approach for arthroscopy under fluoroscopic guidance. For rapid and repeatable sampling, the ankle joint was lavaged three times with the same 7cc of fluid before the total fluid volume was aspirated and the needle withdrawn. SF was transferred to 15 ml conical centrifuge tubes (Falcon, Thermo Fisher Scientific, Waltham, MA), centrifuged at room temperature to remove cells and particulate matter (3,500 RPM, 15 min), 32 and supernatants stored at À80˚C. No adverse events or complications were reported for any patient or joint with this procedure.
Serum Collection
Whole blood was obtained concurrently with SF aspiration in order to measure serum urea concentrations as described below. Collected blood was allowed to sit for 20 min in glass tubes, then centrifuged at room temperature (15 min, 3,500 RPM). The serum fraction was aspirated, aliquoted, labeled, and stored at À80˚C in cryopreservation tubes (Nalgene, Thermo Fisher Scientific, Waltham, MA).
Correction for Dilution Through Lavage
The constant ratio of urea in SF relative to serum regardless of disease state suggests urea as a passive transport marker in arthritis biomarker studies when direct aspiration of SF is difficult. 32, 33 SF and serum urea concentrations were determined using a colorimetric assay (QuantiChrom Urea Assay Kit, BioAssay Systems, Hayward, CA). The dilution factor was calculated by dividing serum urea concentration by SF urea concentration for each ankle from each patient. SF concentrations were corrected for this dilution factor prior to data analysis.
Metabolite Analysis SF samples were submitted for global metabolic profiling (Metabolon, Inc., Durham, NC). To achieve broad detection of small molecules with differing properties, non-targeted metabolic profiling was conducted using three independent platforms: UPLC-MS/MS optimized for basic species, UPLC-MS/MS optimized for acidic species, and GC-MS as described previously. 34, 35 Metabolites were identified by automated comparison of experimental samples to chemical reference library standards and were curated using software developed at Metabolon. 36 Process and instrument quality control was monitored with internal standards, pooled technical replicates, and water blanks carried through the entire process. 34 Instrument variability was determined by calculating the median relative standard deviation (RSD) for standards added to each sample prior to injection into the mass spectrometers. Overall process variability was determined by calculating the median RSD for all endogenous metabolites present in 100% of a pooled SF technical matrix sample injected multiple times per run-day.
Data Manipulation
Metabolite levels in each SF sample were normalized by the corresponding dilution factor as described above, and the 658 LEIMER ET AL. dataset scaled to set the median for all metabolites equal to 1; metabolites that fell below the lower limit of detection were given the minimum value observed for that metabolite for the purpose of statistical analyses. SF samples obtained from one patient were excluded due to a labeling error prior to statistical analyses, resulting in n ¼ 19.
Statistics
Data were log-transformed for statistical analyses. The entire dataset was used for random forest (RF) classification, a supervised classification technique based on decision trees 37, 38 built by selecting a random subset of data and passing the remaining data down the tree to obtain a prediction for each sample. This process is repeated thousands of times to generate the forest. Final classification of each sample is determined by computing the class prediction frequency for the remaining variables over the entire forest. This method is unbiased because the prediction for each sample is based on trees built from a subset of samples that do not include that sample. Class predictions are compared to true classes to determine prediction accuracy, an unbiased estimate of how well one can predict sample class in a new data set.
To determine which metabolites made the largest contribution to the classification, the Mean Decrease Accuracy was computed as a variable importance measure by randomly permuting a variable, running the values through the forest, and then reassessing prediction accuracy. Metabolites important to the classification showed decreased prediction accuracy after such a permutation. Thus, the RF analysis provides an importance rank ordering of metabolites.
Data for lipids in SF of injured and contralateral ankles at baseline were analyzed via matched pairs t-tests (a < 0.01), and that of injured ankles at baseline and 6 months were analyzed using repeated measures ANOVA with post-test contrasts (a < 0.01). Fold change was calculated for both analyses as the mean of ratios of individual patients.
Lipid/Cytokine Correlation Analysis
Correlation analysis was performed for all lipid metabolites found in SF against cytokines and MMPs, which were measured from the same SF samples with sufficient fluid volume as described in previous work. 24 This was done using patient-specific untransformed data, which were correlated across all groups using the CORREL function in Microsoft Excel to yield the Pearson correlation coefficient (r). Pearson's correlation coefficient was tested for significance against the null hypothesis that r ¼ 0 (a < 0.01). For this dataset of n ¼ 19 and a two-tailed analysis, significance was declared if r > 0.575. 39 
Fracture and Injury Classification Analyses
Fracture classification analysis was performed by dividing patients into three groups based on fracture severity (Table 1) : patients with isolated fibula or medial malleolus fracture, or 1n9 or 11) , which each exhibited a greater than 10-fold increase (Table 2 ). In addition, all monohydroxy FAs and sphingolipid metabolites showed significant elevation including 13-HODE þ 9-HODE, 2-hydroxypalmitate, and 2-hydroxystearate, stearoyl sphingomyelin (18:0), and palmitoyl sphingomyelin (16:0). Twelve of the 22 identified lysolipids were significantly elevated and included 1-palmitoylglycerophosphocholine (16:0), 1-stearoylglycerophosphocholine (18:0), 1-arachidonoylglycerophosphoinositol, and 1-oleoylglycerophosphocholine (18:1) ( Table 2 ). The medium chain FA 5-dodecenoate (12:1n7) and glycerolipid metabolite glycerol-3-phosphate (G3P) were also significantly elevated. Representative significant elevations in SF of fractured ankles at baseline compared to contralateral controls are presented in Figure 1 .
Ten of the 15 identified long chain FAs and PUFAs in fractured ankles at baseline had significantly de- (Table 3 ). In contrast, the omega-3 PUFA docosapentaenoate (n3 DPA; 22:5n3) trended toward elevation 6 months post-surgery. Of the long chain and monohydroxy FAs which showed at least a fivefold increase in fractured ankles at baseline, only the long chain FAs oleate (18:1n9), eicosenoate (20:1n9 or 11), 10-heptadecenoate (17:1n7), and myristoleate (14:1n5) had significantly decreased at 6 months ( Table 3) . None of the 22 measured lysolipids in the injured ankles at baseline had significantly decreased at 6 months post-surgery. Stearoyl sphingomyelin (18:0), palmitoyl sphingomyelin (16:0), and medium chain FA 5-dodecenoate (12:1n7) were significantly decreased 6 months after surgery. Table 3 lists additional lipid metabolites which were significantly elevated with a greater than 3.10-fold increase in ankle SF after IA fracture at baseline followed by a significant decrease 6 months post-surgery.
RF classification of injured versus contralateral ankles at baseline showed a predictive accuracy of 84%, with predominantly FAs and lysolipids differentiating between groups. Monohydroxy FAs 2-hydroxypalmitate and 2-hydroxystearate, and medium chain FA 5-dodecenoate (12:1n7) were listed within the top 5 differentiating metabolites (Fig. 2A) (Fig. 2B) . In contrast, RF comparison of injured versus contralateral control ankle SF samples at 6 months showed a predictive accuracy of 64%, with few lipids differentiating between groups and none included in the top five distinguishing metabolites. The predictive accuracy of RF for contralateral control ankles at baseline versus 6 months was 50%.
The most significant correlations between lipid metabolites and cytokines were 2-hydroxypalmitate and MMP-1, 2-hydroxypalmitate and IL-10, 2-hydroxypalmitate and TNF-a, stearoyl sphingomyelin (18:0) and MMP-9, 1-arachidonoylglycerophosphoethanolamine and MMP-9, and G3P and MMP-9 ( Fig. 3) , all with r values of 0.9. As a group, the monohydroxy FA metabolites showed the strongest correlations to MMP-10, MMP-2, GM-CSF, IL-6, bilirubin and biliverdin, MMP-1, IL-10, and TNF-a Stages 2 and 3 fractured ankles were associated with increased medium chain FAs, lysolipids, and inositol metabolites relative to the confidence interval given by the Stage 1 fractured ankles. Stage 3 fractured ankles were also associated with elevated PUFAs, long chain FAs, FA metabolites, glycerolipid 
DISCUSSION
This study was performed to characterize the environment of the SF following IA ankle fracture, with an emphasis on changes in the lipid profile. A global metabolic profile was obtained from SF of 19 IA fractured ankles and also from uninjured contralateral ankles within 17 days of fracture, which revealed a distinctive lipid signature reflective of injury, fracture, and early changes associated with OA. Fractured ankles showed elevated levels of many lipid metabolites, which contributed significantly to broader differences in the biochemistry of the SF.
Metabolic analysis revealed that most long chain FAs and PUFAs were acutely elevated in fractured ankles at baseline compared to patient-matched contralateral control ankles. Many of these same free FAs were found to decrease in the SF of injured joints at 6 months post-surgery, with the exception of omega-3 FAs docosapentaenoate (n3 DPA; 22:5n3), which demonstrated significant elevation at acute injury and subsequently showed a trend toward elevation after 6 months. Moreover, lysolipids with an acyl group at the sn-1 position were also acutely elevated in fractured ankles at baseline compared to contralateral controls. This acute elevation of free FAs and lysolipids suggests possible involvement of a phospholipase A 2 (PLA 2 ) enzyme following acute joint injury, which hydrolyzes membrane phospholipids to release free FAs from the sn-2 position. Secreted PLA 2 s are associated with cytokine-driven development of RA and inflammation, as many PLA 2 s release arachidonic acid to generate inflammatory eicosenoids via the lipoxygenase (LOX) and cyclooxygenase pathways. [40] [41] [42] Two of the resulting sn-1 lysolipids were glycerophosphoinositols (GroPIns) and showed significant elevation in IA fractured ankles at baseline and trended toward elevation at 6 months. Elevated GroPIns have been implicated in Ras activation, 43 including modulating the activity of GTPases to affect cell motility, 44 inhibition of ECM degradation by cancerous cell lines, 44 and stimulation of osteoblast proliferation. 45 GroPIns are also hydrophilic compounds that permeate the cell membrane, suggesting them, or more likely PLA 2 , as candidates for therapeutic intervention. 42 In addition, this elevation of free FAs and lysolipids could be detrimental to the joint, as these metabolites showed strong correlations with MMPs, TNF-a, and bilirubin and biliverdin. Our previous work found that IA fractured joint SF contained significantly more biliverdin and bilirubin than that of the contralateral control ankles. 24 Increased heme breakdown products together with elevated FAs indicate a post-traumatic joint environment characterized by blood and damage LIPID PROFILE FOLLOWING ANKLE FRACTURE to IA joint structures and articular cartilage surfaces. Fracture classification analysis showed that the array of lipid metabolites with elevated concentrations in fractured ankle SF increased as fracture severity increased. Stage 3 fractured ankles were associated with elevated free FAs and lysolipids in the SF, including 1-stearoylglycerophosphoinositol, which could indicate increased PLA 2 activation and subsequent inflammation with possible progression to PTOA. Collectively, these findings suggest that attenuation of PLA 2 activity may be one therapeutic course to limit the progression of PTOA following joint injury.
While glycerophospholipid breakdown was acutely elevated with injury, sphingolipid synthesis also showed acute elevation with increases in sphingomyelins and 2-hydroxyl FAs (hFA-sphingolipids), specialized FAs found in sphingomyelins. 46 hFA-sphingolipids have known functions in the nervous system, skin, kidney, and invasive tumors, and are also involved in cell signaling and differentiation. 46 Phosphatidylcholine, lysophosphotidylcholine, and sphingomyelin progressively increase in the SF of patients with early and late OA. 25 Sphingolipid metabolites and hFA-sphingolipids showed the strongest correlations between lipid metabolites and cytokines in fractured ankle SF. These correlations included cytokines IL-10, MMP-1, and TNF-a, which demonstrated significant elevation in IA fractured ankle SF in previous work. 24 Together, these findings suggest elevated sn-1 lysolipids, sphingomyelins, and subsequent inflammatory lipid mediators in the joint SF as biomarkers of ankle injury, which could lead to PTOA. However, our results indicate that much of this biomarker signature of joint pathology is reversed to nearly control values in fractured joints at 6 months post-surgery. It is possible that the involvement of these metabolites in disease progression may be temporary and subject to modulation, although their elevation acutely post-surgery suggests they may also activate signaling pathways that drive progression to PTOA. These mechanisms which drive progression to PTOA have yet to be elucidated.
Pro-resolving lipid mediator precursors arachidonate (20:4n6) and docosahexaenoate (DHA; 22:6n3) were detected in the current study, although pro-resolving lipid mediators including lipoxins, resolvins, and protectins were not detected in this analysis. In addition to the inflammatory eicosenoids described above, arachidonic acid can also be transformed into lipoxins via specific LOX pathways. 47, 48 Resolvins are derived from the omega-3 FAs docosahexaenoate (DHA; 22:6n3) and eicosapentaenoic acid, and protectins are derived from docosahexaenoate (DHA; 22:6n3). 49 Both detected compounds demonstrated acute elevation in fractured ankles at baseline, and the omega-6 FA arachidonate (20:4n6) showed a significant decrease in fractured ankle SF 6 months post-surgery. These findings indicate a normal physiologic response to trauma, as omega-3 and omega-6 FAs were elevated following acute injury and pro-inflammatory omega-6 FAs showed a significant decrease 6 months post-surgery. This change in lipid composition is reinforced by the resolution of many lipids and lipid metabolites after 6 months as demonstrated by RF analysis.
RF analysis identified lipid metabolites as the most important class of compounds for identification of acute IA ankle fracture, which demonstrated key differences in FAs and lysolipids, sphingomyelin metabolism, and oxidative stress and protein hydrolysis markers. RF classification also revealed that the metabolic profile corresponding to acutely injured ankles is most altered compared to the other groups (i.e., baseline contralateral control, injured and contralateral at 6 months postsurgery). The lower predictive accuracy of RF for injured versus contralateral control ankles at 6 months suggests ongoing resolution of the acute metabolic changes resulting from IA fracture. In addition, the predictive accuracy for the comparison of contralateral control ankles at baseline and 6 months is equivalent to random chance, indicating that the metabolic profiles of the control ankle SF are stable over time.
In addition to RF analysis, minimal significant changes in the contralateral control ankles over time further validates the stability of the control ankles, as only one lysolipid out of all identified lipid metabolites demonstrated a significant change. Similarly, comparison of injured and contralateral control ankles at 6 months showed no significant changes. This indicates resolution of the inflammatory changes in fractured ankles at baseline to values similar to those of the stable contralateral control ankles 6 months postsurgery. Our previous work has analyzed SF from ankles with confirmed PTOA compared to SF from ankles without pain or radiographic evidence of arthritis. 30 This work yielded inflammatory cytokines and metabolites implicated in joint arthropathies and involved with collagen degradation, amino acid catabolism, and lipid metabolism. RF analysis comparing ankles with PTOA and control ankles showed a predictive accuracy of 90%. However, unmatched controls introduce variability due to patient-specific factors such as medications, systemic diseases, and age, which cannot always be accounted for in analyses. The increased statistical power provided by the patient-matched contralateral control ankles in the current study allows for greater ability to detect significant differences between groups and identify more specific biomarkers suggestive of increased risk for PTOA development and as potential targets for intervention. However, the small sample size included in this study represents a potential limitation for interpreting the results. Patient enrollment for this study proved challenging due to the importance of obtaining SF from the uninjured contralateral ankle at both the baseline and 6 month time points.
The SF lipid metabolite profile of IA knee fracture resembles that of bone marrow with increased triglycerides, decreased cholesterol, and few phospholipids. 26 Although the current study found acutely elevated cholesterol in SF of fractured ankles at baseline compared to contralateral control ankles, it was not optimized to detect complex lipids such as triglycerides and phospholipids. For example, limited coverage of phosphatidylcholines meant that these levels could not be compared against lysophosphatidylcholines. This inability to directly compare concentrations of complex lipid classes to those of previous publications represents a potential limitation of the current study. However, the bone and soft tissue injury analysis ensured that the integrity of the ankle joints selected for inclusion in this study was maintained by finding no differences in FA composition of SF between IA fracture only and IA fracture with soft tissue injury. This allows the current study to extend the understanding of changes in lipid composition in the joint space over time after traumatic injury.
In summary, this study characterized the lipid metabolite signature of SF from IA fractured ankles with the contralateral ankle joint of each patient serving as a matched control. Understanding the acute and subsequent metabolomic alterations within the joint is critical to identifying metabolites suggestive of increased risk for PTOA development and as potential targets for intervention.
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